Urine Bacteria as a Test for Melanoma Treatment Response
Part of Cancer, Skin clinical trials.
This study looks at bacteria naturally found in urine to see if they can help diagnose melanoma and predict how well systemic therapy (medicine that spreads throughout the body) will work. Researchers believe the types of bacteria in your urine may reflect how your immune system is responding to melanoma treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have melanoma and your doctor has recommended systemic therapy (medicines like immunotherapy or targeted drugs)
- You are 18 years old or older
- You have not taken antibiotics (by mouth or injection) within the last 8 weeks
- You have not taken probiotic or prebiotic supplements within the last 4 weeks
- You do not currently have other active infections or inflammatory conditions like cellulitis, herpes zoster, or psoriasis
- You do not have any other active cancer besides melanoma (basal cell carcinoma is okay)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether a special PET scan (FDG PET/CT) and a blood test that measures ctDNA (cancer DNA in the blood) can help predict how well immune checkpoint inhibitors work in people with advanced melanoma. If you are planning to get treatment with immunotherapy drugs like ipilimumab, nivolumab, or pembrolizumab, you may be able to join.
This trial looks at tissue and scan-related markers (“biomarkers”) to better understand how immunotherapy works in people with advanced melanoma. You may receive standard first-line immunotherapy, and your recent scans and health details will help researchers study why some people respond better than others.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This trial tests a way to detect circulating melanoma cells (melanoma cells moving in the blood) in real time. If you have melanoma, you may be asked to take part in a session where the team measures your blood during the procedure.
This study looks at the bacteria in your body (microbiome) to see if they can help predict how your bladder cancer will progress. It aims to find patterns that might guide better treatment decisions.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
Hear when a new Melanoma Stage IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.